NR565 WEEK 5: ENDOCRINE SYSTEM CASE STUDY –
HELEN SMITH, ALFONSO GIULIANI, JOHN JONES
(ANSWERED) 100 OUT OF 100 POINTS
CORE DOMAINS
Type 2 Diabetes Mellitus Management
Thyroid Disorders: Hypothyroidism
Thyroid Disorders: Hyperthyroidism (Graves' Disease)
Diabetic Pharmacotherapy
Cardiovascular Risk Reduction in Diabetes
Renal Considerations in Diabetes Management
INTRODUCTION
This comprehensive case study assessment evaluates the advanced
pharmacology knowledge and clinical decision-making skills required for
managing endocrine disorders in primary care. It assesses the ability to
interpret laboratory values, select appropriate pharmacologic agents, and
apply evidence-based guidelines to complex patient scenarios. The case
studies emphasize critical thinking, medication safety, and the integration of
clinical practice guidelines with individualized patient care. This
assessment prepares candidates for the rigor of advanced practice
certification and real-world clinical practice in endocrine management.
SECTION ONE: CASE STUDY QUESTIONS
CASE 1: JOHN JONES – TYPE 2 DIABETES MELLITUS
1. Using diagnostic criteria for diabetes, what is John's diabetic
status?
A. He does not have diabetes
B. He has pre-diabetes
C. He has diabetes but does not require pharmacological intervention
D. He has diabetes and requires pharmacological intervention
D. He has diabetes and requires pharmacological intervention
RATIONALE: John's laboratory values meet the diagnostic criteria for
,diabetes mellitus according to the American Diabetes Association. His
Hemoglobin A1c of 8.1% exceeds the diagnostic threshold of 6.5%, and his
fasting plasma glucose of 148 mg/dL exceeds the threshold of 126 mg/dL.
These values indicate diabetes requiring pharmacological intervention, not
pre-diabetes .
2. What is the first-line pharmacologic therapy for John Jones?
A. Glyburide
B. Metformin
C. Insulin glargine
D. Sitagliptin
B. Metformin
RATIONALE: Metformin is the first-line medication for patients with type
2 diabetes mellitus unless contraindicated. According to the ADA Standards
of Medical Care in Diabetes, metformin is recommended as the initial
pharmacologic agent due to its efficacy, safety, low cost, and potential for
weight neutrality or modest weight loss .
3. Which of the following lab tests should be evaluated before
prescribing metformin?
A. Complete blood count
B. Complete metabolic profile
C. Lipid panel
D. Urinalysis
B. Complete metabolic profile
RATIONALE: A complete metabolic profile (CMP) provides a baseline
evaluation of hepatic and renal function, which must be assessed before
initiating metformin. Metformin is renally excreted, and impaired kidney
function increases the risk of lactic acidosis. The CMP evaluates serum
creatinine and eGFR, which are essential before prescribing metformin .
4. Which behavior in John's social history poses a potential concern
with initiating metformin?
, A. His diet largely consists of fast-food meals
B. He drinks sweet tea with every meal
C. He reports drinking "a few beers on the weekend during football season"
D. He sits at a desk for 8-10 hours daily
C. He reports drinking "a few beers on the weekend during football
season"
RATIONALE: Metformin is contraindicated in patients with excessive
alcohol use because alcohol increases the risk of lactic acidosis by
impairing gluconeogenesis and increasing lactate production. While John
does not appear to have alcoholism, his reported alcohol consumption
warrants further questioning and counseling about the risks of combining
alcohol with metformin .
5. John calls the office and reports that he is scheduled for diagnostic
testing that requires IV contrast for imaging. What instructions should
be given regarding his metformin regimen?
A. No special instructions are needed
B. Take the metformin the morning of the procedure but don't take it for 48
hours afterward
C. Don't take the metformin the day of the procedure but resume the
following day
D. Metformin must be withheld on the day of the procedure and for 48
hours afterward; serum creatinine levels should be normal before resuming
metformin
D. Metformin must be withheld on the day of the procedure and for 48
hours afterward; serum creatinine levels should be normal before resuming
metformin
RATIONALE: IV contrast can cause acute kidney injury, which would
impair metformin clearance and increase the risk of lactic acidosis.
Metformin should be held on the day of the procedure and for 48 hours
afterward. Renal function must be confirmed as normal before resuming
metformin .
HELEN SMITH, ALFONSO GIULIANI, JOHN JONES
(ANSWERED) 100 OUT OF 100 POINTS
CORE DOMAINS
Type 2 Diabetes Mellitus Management
Thyroid Disorders: Hypothyroidism
Thyroid Disorders: Hyperthyroidism (Graves' Disease)
Diabetic Pharmacotherapy
Cardiovascular Risk Reduction in Diabetes
Renal Considerations in Diabetes Management
INTRODUCTION
This comprehensive case study assessment evaluates the advanced
pharmacology knowledge and clinical decision-making skills required for
managing endocrine disorders in primary care. It assesses the ability to
interpret laboratory values, select appropriate pharmacologic agents, and
apply evidence-based guidelines to complex patient scenarios. The case
studies emphasize critical thinking, medication safety, and the integration of
clinical practice guidelines with individualized patient care. This
assessment prepares candidates for the rigor of advanced practice
certification and real-world clinical practice in endocrine management.
SECTION ONE: CASE STUDY QUESTIONS
CASE 1: JOHN JONES – TYPE 2 DIABETES MELLITUS
1. Using diagnostic criteria for diabetes, what is John's diabetic
status?
A. He does not have diabetes
B. He has pre-diabetes
C. He has diabetes but does not require pharmacological intervention
D. He has diabetes and requires pharmacological intervention
D. He has diabetes and requires pharmacological intervention
RATIONALE: John's laboratory values meet the diagnostic criteria for
,diabetes mellitus according to the American Diabetes Association. His
Hemoglobin A1c of 8.1% exceeds the diagnostic threshold of 6.5%, and his
fasting plasma glucose of 148 mg/dL exceeds the threshold of 126 mg/dL.
These values indicate diabetes requiring pharmacological intervention, not
pre-diabetes .
2. What is the first-line pharmacologic therapy for John Jones?
A. Glyburide
B. Metformin
C. Insulin glargine
D. Sitagliptin
B. Metformin
RATIONALE: Metformin is the first-line medication for patients with type
2 diabetes mellitus unless contraindicated. According to the ADA Standards
of Medical Care in Diabetes, metformin is recommended as the initial
pharmacologic agent due to its efficacy, safety, low cost, and potential for
weight neutrality or modest weight loss .
3. Which of the following lab tests should be evaluated before
prescribing metformin?
A. Complete blood count
B. Complete metabolic profile
C. Lipid panel
D. Urinalysis
B. Complete metabolic profile
RATIONALE: A complete metabolic profile (CMP) provides a baseline
evaluation of hepatic and renal function, which must be assessed before
initiating metformin. Metformin is renally excreted, and impaired kidney
function increases the risk of lactic acidosis. The CMP evaluates serum
creatinine and eGFR, which are essential before prescribing metformin .
4. Which behavior in John's social history poses a potential concern
with initiating metformin?
, A. His diet largely consists of fast-food meals
B. He drinks sweet tea with every meal
C. He reports drinking "a few beers on the weekend during football season"
D. He sits at a desk for 8-10 hours daily
C. He reports drinking "a few beers on the weekend during football
season"
RATIONALE: Metformin is contraindicated in patients with excessive
alcohol use because alcohol increases the risk of lactic acidosis by
impairing gluconeogenesis and increasing lactate production. While John
does not appear to have alcoholism, his reported alcohol consumption
warrants further questioning and counseling about the risks of combining
alcohol with metformin .
5. John calls the office and reports that he is scheduled for diagnostic
testing that requires IV contrast for imaging. What instructions should
be given regarding his metformin regimen?
A. No special instructions are needed
B. Take the metformin the morning of the procedure but don't take it for 48
hours afterward
C. Don't take the metformin the day of the procedure but resume the
following day
D. Metformin must be withheld on the day of the procedure and for 48
hours afterward; serum creatinine levels should be normal before resuming
metformin
D. Metformin must be withheld on the day of the procedure and for 48
hours afterward; serum creatinine levels should be normal before resuming
metformin
RATIONALE: IV contrast can cause acute kidney injury, which would
impair metformin clearance and increase the risk of lactic acidosis.
Metformin should be held on the day of the procedure and for 48 hours
afterward. Renal function must be confirmed as normal before resuming
metformin .
